Hjem › Psoriasisartritt › California
Kliniske studier for Psoriasisartritt i California
13 studier for Psoriasisartritt søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Newport Huntington Medical Group, Huntington Beach
- Rheumatology Center of San Diego, San Diego
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07321873Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 105, Santa Monica
RekruttererFase 1
Alder 18 og eldre · Kvinner · Oppdatert 18. sep. 2026 · NCT06888193A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- First OC Dermatology Research Inc., Fountain Valley
- Purushotham & Akther Kotha MD, La Mesa
- Triwest Research Associates LLC, La Mesa
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Medvin Clinical Research - Riverside ( Site 5115), Riverside
- Cohen Medical Centers ( Site 5111), Thousand Oaks
- Medvin Clinical Research - Tujunga ( Site 5113), Tujunga
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, La Jolla
- Clinical Site, Pomona
- Clinical Site, Santa Monica
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- Biovin Enterprises LLC dba Medvin Clinical Research | Covina, CA, Covina
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- First OC Dermatology Research Inc., Fountain Valley
- Purushotham & Akther Kotha MD, La Mesa
- Triwest Research Associates LLC, La Mesa
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07286058Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Children's Hospital of Los Angeles, Los Angeles
- Mattel Children's Hospital at University of California Los Angeles, Los Angeles
- Stanford University Medical Center, Palo Alto
- og 2 flere
RekruttererObservasjonsstudie
Opp til 21 år · Alle kjønn · Oppdatert 27. aug. 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 127, Apple Valley
- Pa0019 111, Covina
- Pa0019 119, Fullerton
- og 6 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT07290036Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
- University of California, San Diego, San Diego
Rekrutterer
Alle aldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06586281Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Newport Huntington Medical Group /ID# 272764, Huntington Beach
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT06865105Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
- University of California, San Diego, La Jolla
RekruttererObservasjonsstudie
Alle aldre · Kvinner · Oppdatert 28. jan. 2025 · NCT02103361Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.